Clinical Study | Office of Clinical Research

Stem Cell Transplant In Mcl With Mutated Tp53

Posted Date: May 6, 2022

Investigator: Bryan Hambley
Type of Study: Observational/Survey

This retrospective study will evaluate outcomes in patients with mantle cell lymphoma with dysfunctional TP53, particularly evaluating if stem cell transplant helps mitigate the negative prognostic outcomes with these patients.

Criteria:

Null

Keywords:

Mantle, Transplant, Tp53

For More Information:

Bryan Hambley
NULL
hamblebc@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List